NaV1.7 oligonucleotides (Korro Bio)

N/A

Report date: 2024/10/29 16:16:59

Base Information

Drug NameNaV1.7 oligonucleotides (Korro Bio)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsChronic Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKorro Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesKorro Bio Inc
Inactive CompaniesN/A
Active IndicationsChronic Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A